BioInvent International AB 2025 SR
The report outlines BioInvent's sustainability strategy and performance for 2025, prepared in accordance with the ISO 26000:2025 standard and incorporating VSME reporting modules. The company conducted a Double Materiality Assessment in 2025, prioritizing four UN Sustainable Development Goals: Good Health and Well-being, Industry, Innovation and Infrastructure, Reduced Inequalities, and Partnerships for the Goals. Key highlights include achieving ISO 26000 verification, maintaining a strong focus on clinical-stage cancer immunotherapy, and implementing robust data privacy and environmental controls.
Company: BioInvent International AB
Sector: Health Care
Country: Sweden
Year: 2025
Type: SR
Pages: 71
Back to company
BioInvent International AB
Sustainability Declaration
The report outlines BioInvent's sustainability strategy and performance for 2025, prepared in accordance with the ISO 26000:2025 standard and incorporating VSME reporting modules. The company conducted a Double Materiality Assessment in 2025, prioritizing four UN Sustainable Development Goals: Good Health and Well-being, Industry, Innovation and Infrastructure, Reduced Inequalities, and Partnerships for the Goals. Key highlights include achieving ISO 26000 verification, maintaining a strong focus on clinical-stage cancer immunotherapy, and implementing robust data privacy and environmental controls.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
2025
Fiscal Year
2025
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Women in Management
Employees